Бабышкина Наталия Николаевна
← Back to Siberian State Medical University
Siberian State Medical University
Бабышкина Наталия Николаевна works in Breast Cancer Treatment Studies, Estrogen and related hormone effects, Breast Lesions and Carcinomas, BRCA gene mutations in cancer, Colorectal Cancer Treatments and Studies. Recorded institutional associations include Russian Academy of Sciences, Siberian State Medical University, Tomsk National Research Medical Center.
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Crosstalk Between the FGFR2 and TP53 Genes in Breast Cancer: Data from an Association Study and Epistatic Interaction Analysis
2011 · 24 citationsPredictive value of vascular endothelial growth factor receptor type 2 in triple-negative breast cancer patients treated with neoadjuvant chemotherapy
2017 · 22 citationsRole of TGF-β signaling in the mechanisms of tamoxifen resistance
2021 · 17 citationsNeoadjuvant chemotherapy for different molecular breast cancer subtypes: a retrospective study in Russian population
2014 · 15 citations[Genetic and clinical and pathological characteristics of breast cancer in premenopausal and postmenopausal women].
2008 · 15 citationsImpact of estrogen receptor α on the tamoxifen response and prognosis in luminal-A-like and luminal-B-like breast cancer
2019 · 15 citationsThe effect of folate-related SNPs on clinicopathological features, response to neoadjuvant treatment and survival in pre- and postmenopausal breast cancer patients
2013 · 13 citationsThe distribution pattern of ERα expression, ESR1 genetic variation and expression of growth factor receptors: association with breast cancer prognosis in Russian patients treated with adjuvant tamoxifen
2016 · 11 citationsNew germline mutations in non-BRCA genes among breast cancer women of Mongoloid origin
2020 · 11 citationsVascular Endothelial Growth Factor Receptor 2 (VEGFR2) Contributes to Tamoxifen Resistance in Estrogen-Positive Breast Cancer Patients
2021 · 10 citationsAssociation of functional −509C>T polymorphism in the TGF-β1 gene with infiltrating ductal breast carcinoma risk in a Russian Western Siberian population
2011 · 7 citationsRelation of EGFR/PI3K/AKT signaling components with tamoxifen efficacy in patients with estrogen-dependent breast cancer
2018 · 6 citationsPathogenicity Reclassification of Genetic Variants Related to Early-Onset Breast Cancer among Women of Mongoloid Origin
2022 · 4 citationsMesenchymal Subtype of Triple-Negative Breast Cancer: A Review of Specific Features
2023 · 4 citationsРецептор фактора роста сосудистого эндотелия типа II (VEGFR2) вносит вклад в формирование резистентности эстрогенположительного рака молочной железы к тамоксифену
2020 · 3 citationsPI3K/AKT/MTOR: CONTRIBUTION TO THE TUMOR PHENOTYPE SENSITIVE TO TAMOXIFEN
2021 · 3 citationsExome Sequencing: the Search for Mutations Associated with Hereditary Breast and Ovarian Cancers in the Tuvan Ethnic Group (A Pilot Study)
2024 · 3 citationsA Systematic Review of the Prevalence of Germline BRCA mutations in North Asia Breast Cancer Patients
2024 · 3 citationsImpact of neoadjuvant chemotargeted therapy in patients with colorectal cancer and synchronous liver metastases in perioperative period
2024 · 3 citationsThe role of epidermal growth factor receptor (EGFR) in the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer patients
2020 · 2 citationsNew mutation of the TP53 gene associated with the hereditary breast cancer in a young Tuvinian woman
2022 · 2 citationsShort-term outcomes of neoadjuvant chemotherapy in colorectal cancer patients with isolated liver metastasis
2022 · 2 citationsROLE OF MORPHOLOGICAL AND GENETIC STRUCTURAL CHARACTERISTICS OF ESTROGEN RECEPTOR ALPHA IN THE DEVELOPMENT OF RESISTANCE TO ENDOCRINOTHERAPY WITH TAMOXIFEN IN PATIENTS WITH LUMINAL BREAST CANCER
2016 · 2 citationsLong-term response with the atypical reaction to nivolumab in microsatellite stability metastatic colorectal cancer: A case report
2024 · 2 citationsWhole Exome Sequencing Revealed Rare Variants in BRCA2, RAD51D, FANGC, CYP24A1 Genes in Breast/Ovarian Cancer Patients from a Small Buryat Ethnic Group
2026 · 2 citations
